Mic Iwashima
Chief Operating Officer bei SATSUMA PHARMACEUTICALS, INC.
Profil
Mic Iwashima is currently the Head of Operations and Vice President at Satsuma Pharmaceuticals, Inc. Prior to this, he attended North Carolina State University for his undergraduate degree.
Aktive Positionen von Mic Iwashima
Unternehmen | Position | Beginn |
---|---|---|
SATSUMA PHARMACEUTICALS, INC. | Chief Operating Officer | 01.01.2017 |
Ausbildung von Mic Iwashima
North Carolina State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Satsuma Pharmaceuticals, Inc.
Satsuma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraines. Its product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, or DHE, which is designed to be self-administered with a proprietary pre-filled, single-use, nasal delivery device. The company was founded by John Kollins on June 21, 2016 and is headquartered in Durham, NC. | Health Technology |